Key result
Glucose-insulin-potassium infusions provide proven benefits in medical and surgical ischemia, with emerging evidence suggesting potential therapeutic value in chronic heart failure.
Answers are grounded in this paper and cite their sources.
Glucose-insulin-potassium infusions may offer cardiovascular benefits across acute myocardial infarction, cardiogenic shock, cardiac surgery, and chronic heart failure.
Glucose, insulin, and the cardiovascular systemThere is increasing evidence to support the beneficial eVects of glucose-insulin-potassium infusions (GIK) in acute myocardial infarction, cardiogenic shock, and cardiac surgery.An article in this issue suggests some benefits may also accrue during the treatment of chronic heart failure. 1
No takes yet. Share an insight, caveat, or question.
Christopher Broomhead (2001) conducted an editorial in Cardiovascular disease (acute myocardial infarction, cardiac surgery, congestive heart failure). Glucose-insulin-potassium (GIK) infusion was evaluated. Glucose-insulin-potassium infusions provide proven benefits in medical and surgical ischemia, with emerging evidence suggesting potential therapeutic value in chronic heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: